These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20564936)

  • 21. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
    J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of circulating cytokines by continuous haemofiltration in patients with systemic inflammatory response syndrome or multiple organ dysfunction syndrome.
    Wakabayashi Y; Kamijou Y; Soma K; Ohwada T
    Br J Surg; 1996 Mar; 83(3):393-4. PubMed ID: 8665203
    [No Abstract]   [Full Text] [Related]  

  • 23. Fetuses delivered following preterm prelabor rupture of the membranes are capable of stimulating a proinflammatory response in endothelial cells.
    Athayde N; Wang J; Wang X; Trudinger B
    J Soc Gynecol Investig; 2005 Feb; 12(2):118-22. PubMed ID: 15695107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal and early neonatal interleukin-6 response.
    Chiesa C; Pacifico L; Natale F; Hofer N; Osborn JF; Resch B
    Cytokine; 2015 Nov; 76(1):1-12. PubMed ID: 25890877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid assay for plasma soluble E-selectin predicts the development of acute respiratory distress syndrome in patients with systemic inflammatory response syndrome.
    Okajima K; Harada N; Sakurai G; Soga Y; Suga H; Terada T; Nakagawa T
    Transl Res; 2006 Dec; 148(6):295-300. PubMed ID: 17162250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole blood interleukin-8 concentrations in capillary and cord blood of neonates for the diagnosis of systemic inflammatory states.
    Kohse KP; Carl A; Steinbach G
    Clin Lab; 2002; 48(9-10):497-503. PubMed ID: 12389710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
    Green J; Doughty L; Kaplan SS; Sasser H; Carcillo JA
    Thromb Haemost; 2002 Feb; 87(2):218-23. PubMed ID: 11858480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamic change in interleukin-18 and its relationships with multiple organ dysfunction syndrome].
    Liu JQ; He ZJ; Lin HY; Yao YM; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):70-2. PubMed ID: 14764217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does disseminated intravascular coagulation lead to multiple organ failure?
    Vincent JL; De Backer D
    Crit Care Clin; 2005 Jul; 21(3):469-77. PubMed ID: 15992668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the clinical epidemiological features of acute cerebral stroke inducing systemic inflammatory response syndrome and multiple organ dysfunction syndrome].
    Liu HB; Tian J; Zhao JX; Song DB; Tian JK
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):294-6. PubMed ID: 18788533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of elective hemofiltration in the management of sepsis and multiple organ failure].
    Molnár Z; Euan S
    Orv Hetil; 1998 May; 139(20):1229-33. PubMed ID: 9619044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antenatal infection/inflammation and fetal tissue injury.
    Murthy V; Kennea NL
    Best Pract Res Clin Obstet Gynaecol; 2007 Jun; 21(3):479-89. PubMed ID: 17363332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FIRS: Neonatal considerations.
    Muraskas J; Astrug L; Amin S
    Semin Fetal Neonatal Med; 2020 Aug; 25(4):101142. PubMed ID: 32912755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.
    Ramírez P; Ferrer M; Gimeno R; Tormo S; Valencia M; Piñer R; Menendez R; Torres A
    Crit Care Med; 2009 May; 37(5):1691-5. PubMed ID: 19325465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of C-reactive protein in predicting fetal inflammatory response syndrome.
    Bartkeviciene D; Pilypiene I; Ramasauskaite D; Zakareviciene J; Lauzikiene D; Silkunas M; Vankeviciute RA; Vaigauskaite B; Drasutiene G; Dumalakiene I
    Ginekol Pol; 2015 Dec; 86(12):926-31. PubMed ID: 26995943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocytosis as a prognostic marker in the development of fetal inflammatory response syndrome.
    Bartkeviciene D; Pilypiene I; Drasutiene G; Bausyte R; Mauricas M; Silkunas M; Dumalakiene I
    Libyan J Med; 2013 Oct; 8(1):21674. PubMed ID: 24161005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of brain injury in newborn infants associated with the fetal inflammatory response syndrome.
    Yap V; Perlman JM
    Semin Fetal Neonatal Med; 2020 Aug; 25(4):101110. PubMed ID: 32303463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic interventions for fetal inflammatory response syndrome (FIRS).
    Xiong Y; Wintermark P
    Semin Fetal Neonatal Med; 2020 Aug; 25(4):101112. PubMed ID: 32303464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Distinct Immune Nature of the Fetal Inflammatory Response Syndrome Type I and Type II.
    Para R; Romero R; Miller D; Galaz J; Done B; Peyvandipour A; Gershater M; Tao L; Motomura K; Ruden DM; Isherwood J; Jung E; Kanninen T; Pique-Regi R; Tarca AL; Gomez-Lopez N
    Immunohorizons; 2021 Sep; 5(9):735-751. PubMed ID: 34521696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.
    Levi M; van der Poll T; Schultz M
    Semin Immunopathol; 2012 Jan; 34(1):167-79. PubMed ID: 21805225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.